Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Launch of the EU large-scale integrating project "BlueGenics" to combat osteoporosis

07.12.2012
Project aims to discover the genetic blueprints for new drugs from marine organisms that could help to prevent and to treat major human diseases such as osteoporosis

Searching for substances from the deep sea to combat osteoporosis and other human common diseases is one of the objectives of the new European research project "BlueGenics" which has received funding of EUR 6 million from the European Commission.

Specifically, the international research team, coordinated by Professor Dr. Werner E.G. Müller from the Institute of Physiological Chemistry of the Mainz University Medical Center, intends to identify and to utilize genetic blueprints from marine organisms, including deep-sea sponges and bacteria, for the production of biomedically relevant substances. The novel research approach provided by this research team will allow the sustainable use of marine resources without negative impact on biodiversity.

"As we can see, by funding this joint large-scale research project the European Union has recognized the need to make every effort to develop new and effective drugs for the prevention and treatment of common diseases, for which efficient therapies are still missing, such as osteoporosis," said the coordinator of the BlueGenics project, Professor Dr. Werner E.G. Müller. "I am extremely glad that this project has now been successfully started. BlueGenics brings together leading researchers from nine countries. The unique and complementary expertise provided by these and their advanced equipment provide an excellent basis to reach the ambitious objectives of this project," Müller continued.

The innovative research concept of BlueGenics offers the chance of achieving extraordinary success as seen by the European Commission. The international team of scientists led by the molecular biologist Professor Dr. Werner E.G. Müller together with NanotecMARIN GmbH, a research-based spin-off company at Mainz University, headed by Professor Dr. Heinz C. Schröder and Professor Dr. Xiaohong Wang, both also from the Institute of Physiological Chemistry at JGU, have developed a research strategy that aims to combine research on biomedical-relevant genes from marine animals and bacteria with the most advanced chemical synthesis and structure analysis techniques. The team led by Müller will use this research approach to develop substances up to pre-clinical testing. In this project, the Mainz team will primarily focus on substances that could be used for prophylaxis and/or therapy of osteoporosis as well as on new antimicrobial peptides and compounds with neuroprotective activity.

Müller and his research team have already demonstrated that bioactive substances can be synthesized by applying recombinant molecular biology techniques. They were able to demonstrate that defensin, a toxin and defense peptide produced by sponges, is bioactive if produced in a recombinant way. "This paves the way for exploiting the large treasure of genetic blueprints present in the world-wide oceans for human benefit," Müller said.

The European project BlueGenics brings together the leading researchers from the areas of marine genomics, biosynthesis, and chemical structure analysis. Participants of this project coordinated by Professor Dr. Werner E.G. Müller at the Mainz University Medical Center are 16 research institutions and industrial companies from Germany, France, Croatia, Portugal, Iceland, Italy, Sweden, UK, and China. According to Professor Dr. Dr. Reinhard Urban, Chief Scientific Officer of the University Medical Center, the EU is well advised to fund projects like BlueGenics: "We are practically just at the beginning to exploit marine resources, especially those from the little-explored deep sea, for biomedical purposes. However, it is now already foreseeable that research on deep-sea organisms is likely to produce remarkable results for our society."

BLUE BIOTECHNOLOGY
The so-called Blue Biotechnology is primarily concerned with the biotechnological use of marine organisms. Of particular interest are sponges and deep-sea bacteria that live under extreme conditions in more than 1,000 meters below the sea level. These organisms are considered to be a source of novel valuable substances that can be used in biotechnology and biomedicine. While the majority of the known enzymes break down on exposure to high temperatures, the biocatalysts produced by deep-sea bacteria remain active under extreme conditions, even in the vicinity of marine hydrothermal vents.

What makes blue technology so interesting for research is the fact that even obviously simple organisms, such as marine sponges, are remarkably similar to humans in many ways. The evolutionary relationship between these oldest animals and human beings is surprisingly close, as the Mainz research team has demonstrated in recent years by means of molecular biological techniques. In addition, these organisms produce a variety of substances that have evolved a high degree of specificity and effectiveness during the course of evolution, and hence have attracted increasing interest with regard to their possible therapeutic use in humans, for example for the treatment of viral infections.

Contact
Professor Dr. Werner E.G. Müller
Institute of Physiological Chemistry, Mainz University Medical Center
phone +49 6131 39-25910, fax +49 6131 39-25243, e-mail: wmueller@uni-mainz.de

Petra Giegerich | idw
Further information:
http://www.uni-mainz.de/presse/15944_ENG_HTML.php
http://www.uni-mainz.de/magazin/874_ENG_HTML.php

More articles from Life Sciences:

nachricht Scientists discover new 'architecture' in corn
21.01.2019 | Louisiana State University

nachricht Nuclear actin filaments determine T helper cell function
21.01.2019 | Universitätsklinikum Heidelberg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ten-year anniversary of the Neumayer Station III

The scientific and political community alike stress the importance of German Antarctic research

Joint Press Release from the BMBF and AWI

The Antarctic is a frigid continent south of the Antarctic Circle, where researchers are the only inhabitants. Despite the hostile conditions, here the Alfred...

Im Focus: Ultra ultrasound to transform new tech

World first experiments on sensor that may revolutionise everything from medical devices to unmanned vehicles

The new sensor - capable of detecting vibrations of living cells - may revolutionise everything from medical devices to unmanned vehicles.

Im Focus: Flying Optical Cats for Quantum Communication

Dead and alive at the same time? Researchers at the Max Planck Institute of Quantum Optics have implemented Erwin Schrödinger’s paradoxical gedanken experiment employing an entangled atom-light state.

In 1935 Erwin Schrödinger formulated a thought experiment designed to capture the paradoxical nature of quantum physics. The crucial element of this gedanken...

Im Focus: Nanocellulose for novel implants: Ears from the 3D-printer

Cellulose obtained from wood has amazing material properties. Empa researchers are now equipping the biodegradable material with additional functionalities to produce implants for cartilage diseases using 3D printing.

It all starts with an ear. Empa researcher Michael Hausmann removes the object shaped like a human ear from the 3D printer and explains:

Im Focus: Elucidating the Atomic Mechanism of Superlubricity

The phenomenon of so-called superlubricity is known, but so far the explanation at the atomic level has been missing: for example, how does extremely low friction occur in bearings? Researchers from the Fraunhofer Institutes IWM and IWS jointly deciphered a universal mechanism of superlubricity for certain diamond-like carbon layers in combination with organic lubricants. Based on this knowledge, it is now possible to formulate design rules for supra lubricating layer-lubricant combinations. The results are presented in an article in Nature Communications, volume 10.

One of the most important prerequisites for sustainable and environmentally friendly mobility is minimizing friction. Research and industry have been dedicated...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Our digital society in 2040

16.01.2019 | Event News

11th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Aachen, 3-4 April 2019

14.01.2019 | Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

 
Latest News

Scientists discover new 'architecture' in corn

21.01.2019 | Life Sciences

Broadband achromatic metalens focuses light regardless of polarization

21.01.2019 | Physics and Astronomy

Nuclear actin filaments determine T helper cell function

21.01.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>